§ BIOTECHNOLOGY
USD · BiotechnologyNGNE
NEUROGENE INC
USDSector · Biotechnology
§ 01 · PRICE
Price action
1D5D1M6MYTD1YMAX
§ 03 · SIGNAL STACK · WHAT THE INPUTS SAY
13F FLOW
62 increased/new, 36 decreased/exited (13F)
AC 13F Analysis
§ 05 · WHO OWNS IT
Top institutional holders
| Fund | Shares | % port | Δ Q/Q |
|---|---|---|---|
| SAMSARA BIOCAPITAL, LLC | 1.7M | 3.4% | ±0% |
| Redmile Group, LLC | 1.5M | 1.9% | ±0% |
| Casdin Capital, LLC | 1.4M | 2.2% | +10% |
| RTW INVESTMENTS, LP | 1.4M | 0.3% | ±0% |
| EcoR1 Capital, LLC | 1.3M | 1.1% | ±0% |
| BlackRock, Inc. | 1.0M | 0.0% | +6% |
◇ AC INTELLIGENCE
Top institutional owners for NGNE as of the most recent 13F reporting period (Q1 2026 · Period ended Mar 31). Δ Q/Q reflects share-count change vs. the prior filing — positive green means adding, negative red means trimming. Cross-reference with the ownership-mix bars below to see which strategy cohort is driving the flow.
§ 06 · WHO OWNS IT · BY STRATEGY
OTHER76.8% · 54 holders
DEALER / BANK12.6% · 20 holders
TACTICAL / MACRO8.6% · 3 holders
PASSIVE / INDEX8.6% · 6 holders
QUALITY / COMPOUNDER7.8% · 10 holders
SYSTEMATIC / QUANT0.3% · 3 holders
INCOME / DEFENSIVE0.1% · 3 holders
◇ AC INTELLIGENCE
Ownership mix by behavioral cohort. Top bars indicate which style of capital dominates the float — passive indexing, quality compounders, dealer/bank, systematic quant, etc. Big quality-compounder share means concentrated active conviction; heavy passive share means flows are dictated by index rebalances, not fundamentals.
§ 07 · INSIDER ACTIVITY · LAST 180 DAYS
NO INSIDER FILINGS
◇ AC INTELLIGENCE
No Form 4 filings on record for NGNE in the last 180 days.